Ignite Creation Date:
2024-05-06 @ 5:50 PM
Last Modification Date:
2024-10-26 @ 2:36 PM
Study NCT ID:
NCT05453903
Status:
RECRUITING
Last Update Posted:
2024-05-23
First Post:
2022-07-08
Brief Title:
A Study of Bleximenib in Combination With Acute Myeloid Leukemia AML Directed Therapies
Sponsor:
Janssen Research Development LLC
Organization:
Janssen Research Development LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-04
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-03-05
Completion Date Type:
ESTIMATED
First Submit Date:
2022-07-08
First Submit QC Date:
July 8 2022
Study First Post Date:
2022-07-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-23
Last Update Post Date:
2024-05-23
Last Update Post Date Type:
ACTUAL